# A Phase II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Subjects With Advanced Lung Cancer

> clinical trial · VERIFIED · 2026-07-21

Status: RECRUITING · Sponsor: Shanghai Henlius Biotech · Condition: Non Small Cell Lung Cancer

- Company: Shanghai Henlius Biotech
- Sector: Non Small Cell Lung Cancer
- Primary source: https://clinicaltrials.gov/study/NCT07253142

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.